SUNNYVALE, Calif., Jan. 5, 2023 /PRNewswire/ -- Ceribell, Inc., developer of the world's first brain monitor for point-of-care seizure detection, announced today that Jane Chao, CEO and Co-founder, will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference. The presentation will take place on Monday, January 9, 2023, at 2:00 p.m. Pacific Standard Time.
Event: 41st Annual J.P. Morgan Healthcare Conference
Date: Monday, January 9, 2023
Time: 2:00 p.m. PST
Ceribell, Inc. (www.ceribell.com), is headquartered in Sunnyvale, CA. Ceribell deploys a cloud-linked, portable electroencephalogram (EEG) device to assess brain waves in minutes to identify the occurrence of seizures in emergency rooms and intensive care units. The Ceribell system can be quickly and easily applied to a patient by any healthcare provider and delivers brain monitoring results within minutes. Ceribell is focused on making EEG widely available, more efficient, and more cost-effective to improve the diagnosis and treatment of neurological conditions for patients at risk for seizures. The Ceribell EEG System first received FDA 510(k) clearance in 2017 and is commercially available in the United States.
Investor Contacts:
Brian Johnston or Laine Morgan
Gilmartin Group LLC
Brian@gilmartinir.com
Laine@gilmartinir.com
SOURCE Ceribell, Inc.
